Add like
Add dislike
Add to saved papers

Transurethral coagulation for radiation-induced hemorrhagic cystitis using Greenlight™ potassium-titanyl-phosphate laser.

OBJECTIVE: The aim of this study was to to demonstrate the initial treatment outcomes of Greenlight™ potassium-titanyl-phosphate (KTP) laser on radiation-induced hemorrhagic cystitis.

BACKGROUND DATA: Hemorrhagic cystitis is a common complication of radiation therapy for pelvic tumors.

MATERIALS AND METHODS: From September 2004 to February 2011, 10 patients with radiation-induced intractable hemorrhagic cystitis underwent transurethral Greenlight KTP laser coagulation of the bladder. The power setting was limited to 20-30 W.

RESULTS: Bleeding stopped in all cases after one session of laser treatment. Mean follow-up time was 17 months (6-36 months). All patients underwent cystoscopy 3 months postoperatively, and no bleeding or significant scar was found. Recurrence of significant bleeding was seen in one case 7 months post-operation, and was again cured by KTP laser. There were no complications from the procedures.

CONCLUSIONS: Our experience suggests that transurethral coagulation using KTP laser is a safe and effective strategy for the treatment of hemorrhagic radiation cystitis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app